Reconsidering the indication of haematopoietic stem cell transplantation for dyskeratosis congenita

Br J Haematol. 2018 Oct;183(1):11-12. doi: 10.1111/bjh.15493. Epub 2018 Jul 5.

Authors

Seiji Kojima¹, Karoline Ehlert²

Affiliations

¹ Department of Paediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
² Paediatric Haematology and Oncology, Greifswald University Hospital, Greifswald, Germany.

PMID: 29978455
DOI: 10.1111/bjh.15493

No abstract available

Keywords: HSCT; danazol; dyskeratosis congenita.

Publication types

Editorial

MeSH terms

Decision Making
Dyskeratosis Congenita / therapy*
Hematopoietic Stem Cell Transplantation*
Humans